Published in Nature Nanotechnology · View the paper (DOI)
Researchers outline a targeted therapeutic strategy to treat triple-negative breast cancer using POLR2A gene targeting. The proposed approach utilizes nanotechnology-based precision-targeting to kill TNBC cells while sparing normal cells, offering hope for improved treatment options.
Coverage from 2 institutions